Day: August 11, 2020

Pandemic-Impacted Revenue Slowly ImprovingNEW YORK, Aug. 11, 2020 (GLOBE NEWSWIRE) — Staffing 360 Solutions, Inc. (NASDAQ: STAF), a company executing an international buy-integrate-build strategy through the acquisition of staffing organizations in the United States and the United Kingdom, today announced Fiscal 2020 second quarter and six-month results, which were impacted by the economic downturn resulting from the COVID-19 pandemic.Brendan Flood, Chairman and Chief Executive Officer said, “Our Q2 results are in line with expectations provided on our previous call as the COVID-19 pandemic surged for the first two-thirds of the quarter. While revenue, gross profit, EBITDA and Adj. EBITDA declined when compared with both Q1 2020 and Q2 2019 — adjusted EBITDA remained positive and gross margin increased modestly. The sequential...

VANCOUVER, British Columbia, Aug. 11, 2020 (GLOBE NEWSWIRE) — ElectraMeccanica Vehicles Corp. (NASDAQ: SOLO) (“ElectraMeccanica” or the “Company”), a designer and manufacturer of electric vehicles including the single-occupant, three-wheeled SOLO EV, reported financial results for the second quarter ended June 30, 2020.Second Quarter and Recent Company HighlightsMade continued progress toward production launch of the Company’s flagship SOLO EV, with initial planned deliveries in the Los Angeles market followed by rollouts in other west coast cities thereafter.Expanded the SOLO retail footprint into additional high-traffic, upscale shopping centers in EV-friendly cities, including Scottsdale, AZ and Portland, OR in September. The Company also currently maintains a SOLO EV storefront at Westfield Century City...

GRAND RAPIDS, Mich., Aug. 11, 2020 (GLOBE NEWSWIRE) — UFP Industries, Inc. (Nasdaq: UFPI) today announced it has issued $150 million of unsecured notes under an existing private shelf facility with a lender, effective August 10, 2020. The notes were issued in the following tranches of $50 million each:  3.04% notes, due August 10, 20323.08% notes, due August 10, 20333.15% notes, due August 10, 2035“Our finance team did an excellent job arranging and completing this transaction,” said CEO Mathew J. Missad. “Although we have a very strong balance sheet and liquidity position, we believe it is advantageous to secure capital at opportune times as we focus on achieving our long-term growth objectives. This capital raise provides us with the ability to continue to pursue strategic acquisitions and capital projects that will fuel our growth,...

PRINCETON, N.J., Aug. 11, 2020 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that Al Altomari, Chairman and Chief Executive Officer, will participate in a panel discussion as part of Maxim Group’s M-Vest Virtual Conference Series: Leading Innovators in Women’s Health, beginning at 10:00 a.m. Eastern Time on Thursday, August 13, 2020. The panel will be moderated by Jason McCarthy, PhD, lead biotechnology analyst at Maxim Group.Webcast Details:Date and Time: Thursday, August 13, 10:00 a.m. Eastern timeRegistration Link: https://bit.ly/2DlgeRWAbout Agile Therapeutics, Inc.Agile Therapeutics is a women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women.  Our product candidates are designed to provide women with contraceptive options...

Robust pipeline anticipated to deliver two Phase 3 and four Phase 2 data events in 2020 and 2021Arcutis currently expects no impact to its previously disclosed clinical timelines due to COVID-19Arcutis development programs address dermatological diseases impacting over 20 million patients in the U.S.Strong financial position with $224.0 million in cash, cash equivalents and marketable securitiesWESTLAKE VILLAGE, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today reported financial results for the quarter ended June 30, 2020, and provided a business update.“Arcutis is uniquely positioned to fill the innovation...

SALT LAKE CITY, Aug. 11, 2020 (GLOBE NEWSWIRE) — Overstock.com, Inc. (NASDAQ:OSTK) (“Overstock”) announced that it has commenced an underwritten public offering of 1,700,000 shares of its common stock, par value $0.0001 per share (the “Common Stock”). In addition, Overstock expects to grant underwriters a 30-day option to purchase up to an additional 255,000 shares of the Common Stock, at the public offering price, less the underwriting discount.Overstock intends to use the net proceeds from the offering for general corporate purposes. BofA Securities and Credit Suisse are acting as book-running managers of the offering. Piper Sandler, Needham & Company, D.A. Davidson & Co. and Wedbush Securities are acting as co-managers of the offering.The offering is being made pursuant to an effective shelf registration statement and...

SAN FRANCISCO, Aug. 11, 2020 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on treating and preventing serious infectious diseases, today provided a corporate update and reported financial results for the second quarter ended June 30, 2020.“Our organization is uniquely positioned and working rapidly to address the urgent need for solutions to the global COVID-19 pandemic” said George Scangos, Ph.D., chief executive officer of Vir. “We plan to enter the clinic with VIR-7831 in August and have prepared for success by putting in place multiple manufacturing, development, and commercialization agreements to rapidly provide access if approved. In addition, we have continued to execute on our other pipeline priorities, starting two new hepatitis B trials and preparing to start new...

TUCSON, Ariz., Aug. 11, 2020 (GLOBE NEWSWIRE) — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported its financial results for the quarter ended June 30, 2020.Recent Accomplishments & Highlights:Entered into a 10-year Commercialization and Distribution Agreement (Master Agreement) with QIAGEN Manchester Limited (QIAGEN), providing the foundation for HTG and QIAGEN to combine their technological and commercial strengths with the goal to offer pharmaceutical companies global development, distribution and commercialization capabilities for companion diagnostic assays developed on the HTG EdgeSeq platform.Introduced three previously released research use only (RUO) assays for use with the Thermo Fisher Scientific Ion Torrent Ion S5 next-generation...

Twirla® on Track for Commercial Launch in Fourth Quarter 2020$87.2 Million in Cash and Cash Equivalents as of June 30, 2020Management to Host Conference Call at 4:30 PM ETPRINCETON, N.J., Aug. 11, 2020 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today reported financial results for the three and six months ended June 30, 2020 and provided a corporate update.“Thanks to the dedication and commitment of the Agile team, we made considerable progress on our objectives and we believe we are on track to launch Twirla in the fourth quarter of 2020. During the second quarter, we transitioned into the final validation phase of manufacturing commercial product. Through Syneos Selling Solutions, our contract sales force partner, we also hired several industry veterans to build out our sales...